Collectively, these studies describe the involvement of IRAK1 in the activation of downstream pathways, including NF-κB and MAPKs/NLRP3/IL-1β, which promote the production of mesenchymal markers that induce a shift in the cellular phenotype of cancer cells. The gene discussed is IL1B; the disease is cancer.